MTOR and autoimmune lymphoproliferative syndrome: In individuals with ALPS-FAS, DNTs have been reported to exhibit increased activity in the phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway (5).